Published on : Feb 23, 2021
Ease of use and portability of the device are major reasons influencing the adoption rate of ambulatory blood pressure monitoring (ABPM) devices. Also, growing prevalence of chronic disorders across the world is providing lucrative opportunities for expansion of the global ambulatory pressure monitoring patient monitors market.
Ambulatory blood pressure monitoring devices aids to monitor blood pressure at regular intervals. 24-hour monitoring devices ensure blood pressure measurement frequently during sleep hours and other resting conditions.
The newly added report “Global Ambulatory Blood Pressure Monitoring (ABPM) Patient Monitors Market Research Report 2020” in RMoz repository provides insights about various factors contributing to growth of the market. It also presents information about several challenges and restraining factors that may limit the growth of the global ambulatory pressure monitoring patient monitors market in coming years.
The report consists of 97 pages, each page depicting different aspects of the market growth. In addition, the analysts have used graphs and statistics to present the information in pictorial form.
The market analysts have done in-depth research to provide details of the drivers and trends shaping the market. They have also visited several engineers and other key operators of the the global ambulatory pressure monitoring patient monitors market to get an idea of possible growth rate in coming years.
High Cost of Blood Pressure Monitoring Device May Restrict Growth of Market
Meanwhile, due to rising geriatric population across the globe, the demand for blood pressure monitoring devices is increasing significantly. This is backed by the fact that elderly population is more susceptible to chronic diseases.
As per a report published by the World Health Organization (WHO), by the end of 2050, geriatric population will constitute of almost 22% of the global population. The number is likely to reach 2 million in 2050, while it 617 million in 2015.
Hypertension (HTN) is one of the serious health condition, posing high risk for cardiovascular morbidity and mortality, both. In addition, people suffering from obesity and diabetes mellitus are more susceptible. Hence, growing prevalence of hypertension is a prominent factor likely to propel growth of the global ambulatory blood pressure monitoring patient monitors market.
However, high cost of devices and limited awareness about the devices in several regions are likely to restrain growth of the ambulatory blood pressure monitoring patient monitor market in coming years.
Increasing Healthcare Expenditure Underpins Adoption Rate of Ambulatory Blood Pressure Monitoring Devices
North America is providing lucrative growth opportunity for expansion of the ambulatory blood pressure monitoring devices. The expansion rate is attributed to increasing expenditure in healthcare infrastructure.
In addition, patients in the region are more inclined towards technologically advanced and digital powered blood pressure monitoring devices. The inclination is providing wide scope for expansion of the regional ambulatory blood pressure monitoring patient monitor market.
Europe seems to be a prominent market in coming years. This is due to rising disposable income of people and stringent health policies.
Meanwhile, Asia Pacific is projected to contribute extensively to growth of the global ambulatory blood pressure monitoring patient monitor market. The contribution rate is attributed to shift towards preventive healthcare choice, rather than proactive healthcare measures.
Get Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2621314
On the other hand, key players are focusing on development of technologically advanced, low-value devices in high-volume. This factor is anticipated to play a crucial role in growth of global ambulatory blood pressure monitoring patient monitor market.
Some of the prominent players operating in the global landscape are Welch Allyn Inc., AViTA Corporation, Bosch + Sohn GmbH u. Co. KG, Microlife AG, GE Healthcare, Beijing Avantgarde Medical Equipment Company Ltd., SunTech Medical Inc., Spacelabs Healthcare Inc., Omron Healthcare Company Ltd., and Schiller AG.